Pancreatic cancer is one of the malignant tumors with strong invasiveness, high degree of deterioration, and low surgical resection rate in the digestive system. Optimizing early diagnosis and developing targeted therapy of pancreatic cancer are the key to improving the survival rate of patients. In the episode, we will give you a comprehensive introduction to pancreatic cancer and its signaling pathways, diagnostic markers, and targeted therapies, as well as Creative Biolabs' antibody-related products and services to help fully understand how important it is to optimize early diagnosis and develop targeted drugs.